This is probably a good place to start accumulating some options.
Federated Hermes is not a home-run kind of stock, but it is a blue-chip name at a very reasonable valuation with great upside potential.
Here's how to play the rail name as we see a shipping shortage yet lots to transport.
I like the chart and elevated implied volatility into the earnings release.
This is a company with a $34 billion market cap. But few have even heard of it.
Shares of Cara Therapeutics, Adverum Biotechnologies and Ardelyx Inc. all took big hits after each company announced unfavorable developments.
Here's why the tech giant stumbled after earnings and what I see as better investments.
I'm going smaller on a trade Thursday with a tight weekly chart that has some explosive upside potential.
Exploding food and grain prices play right into the hands of the fertilizer company.
There's a chance we'll see earnings in May, so traders should keep that in mind.